Search
Close this search box.

July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More

Kuwait oil price down to USD 88.46 pb

The price of Kuwaiti oil went down 43 cents to reach USD 88.46 per barrel on Wednesday as opposed to USD 88.89 last Tuesday, said the Kuwait Petroleum Corporation (KPC) on Thursday.

On a global scale, the price of the Brent crude futures’ contracts w…

Read More

103 settlers storm Al-Aqsa Mosque

Dozens of settlers stormed Al-Aqsa Mosque today, Thursday, through the Mughrabi Gate.

103 extremist settlers and Jewish students stormed Al-Aqsa Mosque, under the protection of the occupation forces.

The settlers performed their prayers during the s…

Read More